Cargando…
Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide with the incidence of recurrence being as high as 88% even among patients who have undergone curative-intent treatment. Despite improvements in overall survival, recurrence remains a challenge necessitat...
Autores principales: | Papaconstantinou, Dimitrios, Tsilimigras, Diamantis I, Pawlik, Timothy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450909/ https://www.ncbi.nlm.nih.gov/pubmed/36090786 http://dx.doi.org/10.2147/JHC.S342266 |
Ejemplares similares
-
Meta-Analysis of Repeat Hepatectomy versus Radiofrequency Ablation for Recurrence of Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022) -
Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022) -
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020) -
The Immunology of Hepatocellular Carcinoma
por: Lawal, Gbemisola, et al.
Publicado: (2021) -
Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021)